[1] Yan Y., Zhou X.E., Novick S.J., Shaw S.J., Li Y., Brunzelle J.S., Melcher K.,
Structures of AMP-Activated Protein Kinase Bound to Novel Pharmacological Activators in Phosphorylated, Non-Phosphorylated, and Nucleotide-Free States.
Journal of Biological Chemistry,
294(3): 953-967 (2019).
[2] Rozpędek W., Pytel D., Nowak-Zduńczyk A., Lewko D., Wojtczak R., Diehl J.A., Majsterek, I.,
Breaking the DNA Damage Response Via Serine/Threonine Kinase Inhibitors to Improve Cancer Treatment. Current medicinal chemistry,
26(8): 1425-1445 (2019).
[3] Uitdehaag J.C., de Man J., Willemsen-Seegers N., Prinsen M.B., Libouban M.A., Sterrenburg J.G., Zaman G.J.,
Target Residence Time-Guided Optimization on TTK Kinase Results in Inhibitors with Potent Anti-Proliferative Activity.
Journal of Molecular Biology,
429(14): 2211-2230 (2017).
[4] Guccione M., Ettari R., Taliani S., Da Settimo F., Zappalà M., Grasso S.,
G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitors: Current Trends and Future Perspectives.
Journal of medicinal chemistry,
59(20): 9277-9294 (2016).
[5] Thal D.M., Homan K.T., Chen J., Wu E.K., Hinkle P.M., Huang Z.M., Tesmer J.J.,
Paroxetine is a Direct Inhibitor of G Protein-Coupled Receptor Kinase 2 and Increases Myocardial Contractility.
ACS chemical biology,
7(11): 1830-1839 (2012).
[7] Lian X., Xia Z., Li X., Karpov P., Jin H., Tetko I.V., Wu S.,
Anti-MRSA Drug Discovery by Ligand-Based Virtual Screening and Biological Evaluation.
Bioorganic Chemistry,
114: 105042 (2021).
[8] Mahdian S., Zarrabi M., Moini A., Shahhoseini M., Movahedi M.,
In Silico Evidence for Prednisone and Progesterone Efficacy in Recurrent Implantation Failure Treatment.
Journal of Molecular Modeling,
28(4): 105 (2022).
[12] Azmian Moghadam F., Kefayati H., Evazalipour M., Ghasemi S., Design, Synthesis,
Biological Evaluation, and Docking Study of Novel 4-Anilinoquinazolines Derivatives as Anticancer Agents,
Iranian Journal of Chemistry and Chemical Engineering (IJCCE),
41: 353-367 (2022).
[13] Ibeji C.U., Oguejiofo U., Chukwuma Chime C., Akpomie K.G., Anarado C.J.O., Odewole O.A., Grishina M., Potemkin V., Dehydroacetic
Acid-Phenylhydrazone as a Potential Inhibitor for Wild-Type HIV-1 Protease: Structural, DFT, Molecular Dynamics, 3D QSAR and ADMET Characteristics,
Iranian Journal of Chemistry and Chemical Engineering, 40: 215-230 (2021).
[14] Zuo K., Qian J., Gong J., Zhang J., Li H., Zhou G.,
Synthesis, Characterization, Molecular Docking and Cytotoxicity Studies of Bagasse Xylem Ferulate-Acrylamide/Methyl Methacrylate Composite,
Iranian Journal of Chemistry and Chemical Engineering (IJCCE), 38: 107-116. (2019).
[17] Setyawan J., Koide K., Diller T.C., Bunnage M.E., Taylor S.S., Nicolaou K.C., Brunton L.L.,
Inhibition of Protein Kinases by Balanol: Specificity Within the Serine/Threonine Protein Kinase Subfamily. Molecular pharmacology,
56(2): 370-376 (1999).
[18] Thal D.M., Yeow R.Y., Schoenau C., Huber J., Tesmer J.J.G.,
Molecular Mechanism of Selectivity among G Protein-Coupled Receptor Kinase 2 Inhibitors,
Molecular Pharmacology,
80: 294-303 (2011).
[19] Homan K.T., Larimore K.M., Elkins J.M., Szklarz M., Knapp S., Tesmer J.J.,
Identification and Structure–Function Analysis of Subfamily Selective G Protein-Coupled Receptor Kinase Inhibitors. ACS chemical biology,
10(1): 310-319 (2015).
[20] Kim S., Chen J., Cheng T., Gindulyte A., He J., He S., Bolton E.E.,
PubChem in 2021: New Data Content and Improved Web Interfaces.
Nucleic acids research,
49(D1): D1388-D1395 (2021).
[21] O'Boyle N.M., Banck M., James C.A., Morley C., Vandermeersch T., Hutchison G.R.,
Open Babel: An Open Chemical Toolbox.
Journal of cheminformatics,
3(1): 1-14 (2011).
[22] Morris G.M., Huey R., Lindstrom W., Sanner M.F., Belew R.K., Goodsell D.S., Olson A.J.,
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility.
Journal of computational chemistry,
30(16): 2785-2791 (2009).
[24] Xiong G., Wu Z., Yi J., Fu L., Yang Z., Hsieh C., Cao D.,
ADMETlab 2.0: an Integrated Online Platform for Accurate and Comprehensive Predictions of ADMET Properties.
Nucleic Acids Research,
49(W1): W5-W14 (2021).
[25] Dong J., Wang N.N., Yao Z.J., Zhang L., Cheng Y., Ouyang D., Cao D.S.,
ADMETlab: a Platform for Systematic ADMET Evaluation Based on a Comprehensively Collected ADMET Database.
Journal of cheminformatics,
10: 1-11 (2018).
